Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022

SELL
$72.28 - $90.54 $4.94 Million - $6.19 Million
-68,406 Closed
0 $0
Q3 2021

Nov 03, 2021

BUY
$71.68 - $78.83 $4.9 Million - $5.39 Million
68,406 New
68,406 $5.14 Million
Q2 2021

Aug 04, 2021

SELL
$70.31 - $77.77 $4.03 Million - $4.45 Million
-57,281 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$68.86 - $81.11 $1.07 Million - $1.26 Million
15,500 Added 37.1%
57,281 $4.42 Million
Q4 2020

Feb 02, 2021

BUY
$71.77 - $79.65 $2.66 Million - $2.96 Million
37,116 Added 795.63%
41,781 $3.42 Million
Q3 2020

Oct 28, 2020

SELL
$73.18 - $82.95 $474,865 - $538,262
-6,489 Reduced 58.18%
4,665 $387,000
Q2 2020

Aug 05, 2020

SELL
$70.42 - $80.13 $1.42 Million - $1.61 Million
-20,116 Reduced 64.33%
11,154 $863,000
Q1 2020

May 05, 2020

BUY
$63.36 - $87.82 $1.45 Million - $2.01 Million
22,919 Added 274.45%
31,270 $2.41 Million
Q4 2019

Jan 29, 2020

SELL
$77.58 - $87.54 $15,516 - $17,508
-200 Reduced 2.34%
8,351 $760,000
Q3 2019

Oct 30, 2019

SELL
$76.08 - $82.93 $980,442 - $1.07 Million
-12,887 Reduced 60.11%
8,551 $720,000
Q2 2019

Jul 29, 2019

BUY
$69.84 - $81.59 $1.5 Million - $1.75 Million
21,438 New
21,438 $1.8 Million
Q1 2019

Apr 25, 2019

SELL
$69.58 - $79.36 $212,149 - $241,968
-3,049 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$65.24 - $75.71 $22,899 - $26,574
-351 Reduced 10.32%
3,049 $233,000
Q3 2018

Oct 30, 2018

BUY
$57.69 - $67.84 $196,146 - $230,656
3,400 New
3,400 $241,000
Q1 2018

Apr 27, 2018

SELL
$50.96 - $59.23 $7.15 Million - $8.31 Million
-140,251 Closed
0 $0
Q4 2017

Feb 05, 2018

SELL
$51.62 - $61.64 $376,826 - $449,972
-7,300 Reduced 4.95%
140,251 $7.89 Million
Q3 2017

Nov 02, 2017

BUY
$58.67 - $63.13 $8.66 Million - $9.31 Million
147,551
147,551 $9.45 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Stoneridge Investment Partners LLC Portfolio

Follow Stoneridge Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stoneridge Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stoneridge Investment Partners LLC with notifications on news.